Monte Rosa Therapeutics Statistics
Total Valuation
GLUE has a market cap or net worth of $313.70 million. The enterprise value is -$15.73 million.
Important Dates
The last earnings date was Thursday, March 20, 2025, before market open.
Earnings Date | Mar 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GLUE has 61.51 million shares outstanding. The number of shares has increased by 43.80% in one year.
Current Share Class | 61.51M |
Shares Outstanding | 61.51M |
Shares Change (YoY) | +43.80% |
Shares Change (QoQ) | +0.13% |
Owned by Insiders (%) | 0.96% |
Owned by Institutions (%) | 60.40% |
Float | 33.92M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.98 |
Forward PS | 10.93 |
PB Ratio | 1.41 |
P/TBV Ratio | 1.41 |
P/FCF Ratio | 8.25 |
P/OCF Ratio | 7.47 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.19.
Current Ratio | 2.40 |
Quick Ratio | 2.37 |
Debt / Equity | 0.19 |
Debt / EBITDA | n/a |
Debt / FCF | 1.12 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.15% and return on invested capital (ROIC) is -20.65%.
Return on Equity (ROE) | -36.15% |
Return on Assets (ROA) | -13.66% |
Return on Invested Capital (ROIC) | -20.65% |
Return on Capital Employed (ROCE) | -28.78% |
Revenue Per Employee | $564,343 |
Profits Per Employee | -$542,537 |
Employee Count | 134 |
Asset Turnover | 0.20 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, GLUE has paid $2.57 million in taxes.
Income Tax | 2.57M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.56% in the last 52 weeks. The beta is 1.50, so GLUE's price volatility has been higher than the market average.
Beta (5Y) | 1.50 |
52-Week Price Change | -27.56% |
50-Day Moving Average | 6.13 |
200-Day Moving Average | 6.08 |
Relative Strength Index (RSI) | 35.58 |
Average Volume (20 Days) | 833,715 |
Short Selling Information
The latest short interest is 7.03 million, so 11.44% of the outstanding shares have been sold short.
Short Interest | 7.03M |
Short Previous Month | 8.04M |
Short % of Shares Out | 11.44% |
Short % of Float | 20.74% |
Short Ratio (days to cover) | 13.40 |
Income Statement
In the last 12 months, GLUE had revenue of $75.62 million and -$72.70 million in losses. Loss per share was -$0.98.
Revenue | 75.62M |
Gross Profit | -37.24M |
Operating Income | -81.11M |
Pretax Income | -129.93M |
Net Income | -72.70M |
EBITDA | -72.99M |
EBIT | -81.11M |
Loss Per Share | -$0.98 |
Full Income Statement Balance Sheet
The company has $372.15 million in cash and $42.72 million in debt, giving a net cash position of $329.43 million or $5.36 per share.
Cash & Cash Equivalents | 372.15M |
Total Debt | 42.72M |
Net Cash | 329.43M |
Net Cash Per Share | $5.36 |
Equity (Book Value) | 222.94M |
Book Value Per Share | 3.62 |
Working Capital | 220.49M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $42.00 million and capital expenditures -$3.99 million, giving a free cash flow of $38.01 million.
Operating Cash Flow | 42.00M |
Capital Expenditures | -3.99M |
Free Cash Flow | 38.01M |
FCF Per Share | $0.62 |
Full Cash Flow Statement Margins
Gross margin is -49.25%, with operating and profit margins of -107.26% and -96.14%.
Gross Margin | -49.25% |
Operating Margin | -107.26% |
Pretax Margin | -92.74% |
Profit Margin | -96.14% |
EBITDA Margin | -96.52% |
EBIT Margin | -107.26% |
FCF Margin | 50.26% |
Dividends & Yields
GLUE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -43.80% |
Shareholder Yield | n/a |
Earnings Yield | -23.18% |
FCF Yield | 12.12% |
Analyst Forecast
The average price target for GLUE is $14.33, which is 180.98% higher than the current price. The consensus rating is "Buy".
Price Target | $14.33 |
Price Target Difference | 180.98% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 1.09% |
EPS Growth Forecast (5Y) | 12.89% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
GLUE has an Altman Z-Score of -0.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.3 |
Piotroski F-Score | 2 |